These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 17320883)

  • 21. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
    Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
    Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
    Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
    Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
    Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
    Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice.
    Burgess B; Naus K; Chan J; Hirsch-Reinshagen V; Tansley G; Matzke L; Chan B; Wilkinson A; Fan J; Donkin J; Balik D; Tanaka T; Ou G; Dyer R; Innis S; McManus B; Lütjohann D; Wellington C
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1731-7. PubMed ID: 18599800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
    Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
    Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo.
    de Haan W; Out R; Berbée JF; van der Hoogt CC; van Dijk KW; van Berkel TJ; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1294-8. PubMed ID: 18992221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-x inactivation in macrophages accelerates progression of advanced atherosclerotic lesions in Apoe(-/-) mice.
    Shearn AI; Deswaerte V; Gautier EL; Saint-Charles F; Pirault J; Bouchareychas L; Rucker EB; Beliard S; Chapman J; Jessup W; Huby T; Lesnik P
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1142-9. PubMed ID: 22383704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
    Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice.
    Yu H; Zhang W; Yancey PG; Koury MJ; Zhang Y; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):150-6. PubMed ID: 16269665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
    Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
    Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
    Ishiguro H; Yoshida H; Major AS; Zhu T; Babaev VR; Linton MF; Fazio S
    J Biol Chem; 2001 Sep; 276(39):36742-8. PubMed ID: 11477092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
    Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
    Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting macrophage survival delays progression of pre-existing atherosclerotic lesions through macrophage-derived apoE.
    Bouchareychas L; Pirault J; Saint-Charles F; Deswaerte V; Le Roy T; Jessup W; Giral P; Le Goff W; Huby T; Gautier EL; Lesnik P
    Cardiovasc Res; 2015 Oct; 108(1):111-23. PubMed ID: 26092098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
    Boisvert WA; Curtiss LK
    J Lipid Res; 1999 May; 40(5):806-13. PubMed ID: 10224149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.